U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07033585) titled 'Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers' on June 16.
Brief Summary: Use Dapagliflozin 10 mg, Saxagliptin 5 mg, Metformin 500 mg treat type 2 diabetes patients with controlled cancers
Study Start Date: June 15
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes
Intervention:
DRUG: Farxiga(R) (dapagliflozin) + Onglyza(R) (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes
Farxiga(R) (dapagliflozin) 10 mg, Onglyza(R) (saxagliptin) 5 mg, Metformin 500 mg, Oral Mix Prescription Treat type 2 diabetes patients with controlled cancers
DRUG: China Import (dapaglifloz...